RESUMEN
Novel coronavirus 2019 (COVID-19) is a severe respiratory infection leading to acute respiratory distress syndrome [ARDS] accounting for thousands of cases and deaths across the world. Several alternatives in treatment options have been assessed and used in this patient population. However, when mechanical ventilation and prone positioning are unsuccessful, venovenous extracorporeal membrane oxygenation [VV-ECMO] may be used. We present a case of a 62-year-old female, diabetic, admitted to the intensive care unit with fever, flu-like symptoms and a positive COVID-19 test. Ultimately, she worsened on mechanical ventilation and prone positioning and required VV-ECMO. The use of VV-ECMO in COVID-19 infected patients is still controversial. While some studies have shown a high mortality rate despite aggressive treatment, such as in our case, the lack of large sample size studies and treatment alternatives places healthcare providers against a wall without options in patients with severe refractory ARDS due to COVID-19.
Asunto(s)
Betacoronavirus , Terapia de Reemplazo Renal Continuo/métodos , Infecciones por Coronavirus/complicaciones , Enfermedad Crítica , Oxigenación por Membrana Extracorpórea/instrumentación , Neumonía Viral/complicaciones , Lesión Renal Aguda/etiología , Lesión Renal Aguda/terapia , Antibacterianos/uso terapéutico , Antivirales/uso terapéutico , Bacteriemia/complicaciones , COVID-19 , Terapia Combinada , Terapia de Reemplazo Renal Continuo/instrumentación , Infecciones por Coronavirus/tratamiento farmacológico , Enfermedad Crítica/terapia , Síndrome de Liberación de Citoquinas/etiología , Diabetes Mellitus Tipo 2/complicaciones , Resultado Fatal , Femenino , Infecciones por Bacterias Grampositivas/complicaciones , Humanos , Persona de Mediana Edad , Marruecos , Pandemias , Respiración Artificial , Síndrome de Dificultad Respiratoria/etiología , SARS-CoV-2 , Tratamiento Farmacológico de COVID-19RESUMEN
Novel coronavirus 2019 (COVID-19) is a severe respiratory infection leading to acute respiratory distress syndrome [ARDS] accounting for thousands of cases and deaths across the world. Several alternatives in treatment options have been assessed and used in this patient population. However, when mechanical ventilation and prone positioning are unsuccessful, venovenous extracorporeal membrane oxygenation [VV-ECMO] may be used. We present a case of a 62-year-old female, diabetic, admitted to the intensive care unit with fever, flu-like symptoms and a positive COVID-19 test. Ultimately, she worsened on mechanical ventilation and prone positioning and required VV-ECMO. The use of VV-ECMO in COVID-19 infected patients is still controversial. While some studies have shown a high mortality rate despite aggressive treatment, such as in our case, the lack of large sample size studies and treatment alternatives places healthcare providers against a wall without options in patients with severe refractory ARDS due to COVID-19.